You are here

P&T News

May 3

New Company Will Build Upon Strength of Current Therapies for Hemophilia A and B
New CDC data show large percentage of antibiotics misused in outpatient settings
NEI-funded study of bevacizumab and ranibizumab examines their effects at five years
Better prevention, care will help cut more infections, said researchers from Penn Medicine and Johns Hopkins

May 2

Allergan’s rosuvastatin calcium joins a $6.5 billion market
Subcutaneous nonopioid relieves pain with less toxicity and abuse potential
First and only FDA-approved drug for Parkinson-associated hallucinations and delusions
Registry will provide long-term safety and effectiveness data
Possible link to long wait times for VA care

April 29

Combo treatment with lenalidomide and dexamethasone extends progression-free survival
Topoisomerase 1 inhibitors may blunt inflammatory storms
First authorized test from commercial lab in U.S.

April 28

Medicare EHR incentive system will be phased out
Guidance emphasizes individualized treatment

Pages